ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RNAC Cartesian Therapeutics Inc

27.29
-2.00 (-6.83%)
Jun 15 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 198,234
Bid Price 24.64
Ask Price 42.91
News -
Day High 28.77

Low
11.665

52 Week Range

High
42.60

Day Low 26.32
Company Name Stock Ticker Symbol Market Type
Cartesian Therapeutics Inc RNAC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.00 -6.83% 27.29 00:00:07
Open Price Low Price High Price Close Price Prev Close
28.77 26.32 28.77 27.29 29.29
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,136 198,234 $ 27.04 $ 5,359,380 - 11.665 - 42.60
Last Trade Time Type Quantity Stock Price Currency
16:05:06 priorref 500 $ 27.29 USD

Cartesian Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.41B 161.95M - 26M -219.71M -1.36 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cartesian Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RNAC Message Board. Create One! See More Posts on RNAC Message Board See More Message Board Posts

Historical RNAC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week33.7637.0026.3231.8971,804-6.47-19.16%
1 Month26.6341.8723.5130.3886,2240.662.48%
3 Months21.20141.8711.66519.70197,0376.0928.72%
6 Months21.84341.8711.66520.96483,1525.4524.94%
1 Year24.19542.6011.66523.56592,2603.1012.79%
3 Years24.19542.6011.66523.56592,2603.1012.79%
5 Years24.19542.6011.66523.56592,2603.1012.79%

Cartesian Therapeutics Description

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.

Your Recent History

Delayed Upgrade Clock